戊型肝炎重症化与慢性化免疫学机制研究进展
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R512.6

基金项目:

江苏省卫生健康发展研究中心开放课题(JSHD2022046)


Research advances in the immune pathogenesis of severe and chronic progeression of hepatitis E
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    戊型肝炎是由戊型肝炎病毒感染引起的一种传染性疾病,是全球范围内的重要公共卫生问题。尽管戊型肝炎通常被认为是一种无症状、自限性疾病,但其临床表现呈多样性变化,部分患者可出现重症化或慢性化进展,造成不良预后,危害较为严重。免疫反应是决定戊型肝炎患者临床表现和结局的关键因素,正常的免疫反应有助于病毒清除和疾病康复,而过度或紊乱的免疫反应则可参与其重症化和慢性化进程,导致疾病进展。本文通过文献回顾,从天然免疫反应和适应性免疫反应两个方面对戊型肝炎重症化及慢性化的免疫学机制进行综述,以期为该类患者的早期预测、临床防治和疾病管理提供理论依据和新思路。

    Abstract:

    Hepatitis E is an infectious disease caused by hepatitis E virus(HEV)infection,which is a significant public health concern worldwide. Although hepatitis E is generally considered an asymptomatic,self-limiting disease,its clinical manifestations vary, some patients may develop severe or chronic progression,resulting in poor prognosis and serious harm. Immune response is a key factor determining the clinical manifestation and outcome of hepatitis E. Normal immune response facilitates the clearance of virus and recovery from this disease,while excessive or disordered immune response can participate in severe and chronic progression of the disease,leading to disease progression. Through literature review,this article summarizes the immunological mechanisms of HEV related liver failure and chronic hepatitis E,including innate immune response and adaptive immune response,in order to provide theoretical basis and new ideas for early prediction,clinical prevention and treatment,and disease management.

    参考文献
    相似文献
    引证文献
引用本文

东瑞,黄丽丽,王洁.戊型肝炎重症化与慢性化免疫学机制研究进展[J].南京医科大学学报(自然科学版),2023,(10):1464-1469

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-04-07
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-23
  • 出版日期:
通知关闭
郑重声明